Your browser doesn't support javascript.
loading
mTOR intersects antibody-inducing signals from TACI in marginal zone B cells.
Sintes, Jordi; Gentile, Maurizio; Zhang, Shuling; Garcia-Carmona, Yolanda; Magri, Giuliana; Cassis, Linda; Segura-Garzón, Daniel; Ciociola, Alessandra; Grasset, Emilie K; Bascones, Sabrina; Comerma, Laura; Pybus, Marc; Lligé, David; Puga, Irene; Gutzeit, Cindy; He, Bing; DuBois, Wendy; Crespo, Marta; Pascual, Julio; Mensa, Anna; Aróstegui, Juan Ignacio; Juan, Manel; Yagüe, Jordi; Serrano, Sergi; Lloreta, Josep; Meffre, Eric; Hahne, Michael; Cunningham-Rundles, Charlotte; Mock, Beverly A; Cerutti, Andrea.
Afiliação
  • Sintes J; Program for Inflammatory and Cardiovascular Disorders, Institut Hospital del Mar d'Investigacions Mèdiques (IMIM), Barcelona, 08003, Spain. jsintes@imim.es.
  • Gentile M; Program for Inflammatory and Cardiovascular Disorders, Institut Hospital del Mar d'Investigacions Mèdiques (IMIM), Barcelona, 08003, Spain.
  • Zhang S; Laboratory of Cancer Biology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD, 20892, USA.
  • Garcia-Carmona Y; Department of Medicine and Pediatrics, Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA.
  • Magri G; Program for Inflammatory and Cardiovascular Disorders, Institut Hospital del Mar d'Investigacions Mèdiques (IMIM), Barcelona, 08003, Spain.
  • Cassis L; Program for Inflammatory and Cardiovascular Disorders, Institut Hospital del Mar d'Investigacions Mèdiques (IMIM), Barcelona, 08003, Spain.
  • Segura-Garzón D; Program for Inflammatory and Cardiovascular Disorders, Institut Hospital del Mar d'Investigacions Mèdiques (IMIM), Barcelona, 08003, Spain.
  • Ciociola A; Program for Inflammatory and Cardiovascular Disorders, Institut Hospital del Mar d'Investigacions Mèdiques (IMIM), Barcelona, 08003, Spain.
  • Grasset EK; Department of Medicine, Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA.
  • Bascones S; Department of Medicine, Center for Molecular Medicine at Karolinska University Hospital, Karolinska Institutet, Stockholm, 171 76, Sweden.
  • Comerma L; Program for Inflammatory and Cardiovascular Disorders, Institut Hospital del Mar d'Investigacions Mèdiques (IMIM), Barcelona, 08003, Spain.
  • Pybus M; Program for Inflammatory and Cardiovascular Disorders, Institut Hospital del Mar d'Investigacions Mèdiques (IMIM), Barcelona, 08003, Spain.
  • Lligé D; Program for Inflammatory and Cardiovascular Disorders, Institut Hospital del Mar d'Investigacions Mèdiques (IMIM), Barcelona, 08003, Spain.
  • Puga I; Program for Inflammatory and Cardiovascular Disorders, Institut Hospital del Mar d'Investigacions Mèdiques (IMIM), Barcelona, 08003, Spain.
  • Gutzeit C; Program for Inflammatory and Cardiovascular Disorders, Institut Hospital del Mar d'Investigacions Mèdiques (IMIM), Barcelona, 08003, Spain.
  • He B; Department of Medicine, Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA.
  • DuBois W; Department of Medicine, Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA.
  • Crespo M; Laboratory of Cancer Biology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD, 20892, USA.
  • Pascual J; Department of Nephrology, Institut Hospital del Mar d'Investigacions Mèdiques (IMIM), Barcelona, 08003, Spain.
  • Mensa A; Department of Nephrology, Institut Hospital del Mar d'Investigacions Mèdiques (IMIM), Barcelona, 08003, Spain.
  • Aróstegui JI; Immunology Service, Hospital Clínic of Barcelona, Barcelona, 08036, Spain.
  • Juan M; Immunology Service, Hospital Clínic of Barcelona, Barcelona, 08036, Spain.
  • Yagüe J; Immunology Service, Hospital Clínic of Barcelona, Barcelona, 08036, Spain.
  • Serrano S; Immunology Service, Hospital Clínic of Barcelona, Barcelona, 08036, Spain.
  • Lloreta J; Department of Pathology, Hospital del Mar, Barcelona, 08003, Spain.
  • Meffre E; Universitat Pompeu Fabra, Barcelona, 08003, Spain.
  • Hahne M; Department of Pathology, Hospital del Mar, Barcelona, 08003, Spain.
  • Cunningham-Rundles C; Universitat Pompeu Fabra, Barcelona, 08003, Spain.
  • Mock BA; Department of Immunobiology, Yale University, New Haven, CT, 06511, USA.
  • Cerutti A; Molecular Genetics Institute of Montpellier, Montpellier, 34293, France.
Nat Commun ; 8(1): 1462, 2017 11 13.
Article em En | MEDLINE | ID: mdl-29133782
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Imunoglobulina G / Linfócitos B / Fator 88 de Diferenciação Mieloide / Proteína Transmembrana Ativadora e Interagente do CAML / Serina-Treonina Quinases TOR / Alvo Mecanístico do Complexo 1 de Rapamicina Limite: Animals / Humans Idioma: En Ano de publicação: 2017 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Imunoglobulina G / Linfócitos B / Fator 88 de Diferenciação Mieloide / Proteína Transmembrana Ativadora e Interagente do CAML / Serina-Treonina Quinases TOR / Alvo Mecanístico do Complexo 1 de Rapamicina Limite: Animals / Humans Idioma: En Ano de publicação: 2017 Tipo de documento: Article